References
- De Los RP, Hill DJ. (2000). Expression and release of insulin-like growth factor binding proteins in isolated epiphyseal growth plate chondrocytes from the ovine fetus. J Cell Physiol 183:172–81
- Downey CM, Horton CR, Carlson BA, et al. (2009). Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin–Beck disease. PLoS Genet 5:e1000616
- Du XH, Dai XX, Xia SR, et al. (2012). SNP and mRNA expression for glutathione peroxidase 4 in Kashin–Beck disease. Br J Nutr 107:164–9
- Firth SM, Baxter RC. (2002). Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824–54
- Fukushima T, Tezuka T, Shimomura T, et al. (2007). Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. J Biol Chem 282:18634–44
- Kiepe D, Ulinski T, Powell DR, et al. (2002). Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes. Kidney Int 62:1591–600
- Li S, Cao J, Caterson B, et al. (2012). Proteoglycan metabolism, cell death and Kashin–Beck disease. Glycoconj J 29:241–8
- Meng FG, Fu Y, Wang LH. (2001). The effect evaluation of the prevention of Kashin–Beck disease by the change of food and selenium supplementary. Chin J Ctrl Endem Dis 26:188–90
- Moreno-Reyes R, Egrise D, Neve J, et al. (2001). Selenium deficiency-induced growth retardation is associated with an impaired bone metabolism and osteopenia. J Bone Miner Res 16:1556–63
- Moreno-Reyes R, Mathieu F, Boelaert M, et al. (2003). Selenium and iodine supplementation of rural Tibetan children affected by Kashin–Beck osteoarthropathy. Am J Clin Nutr 78:137–44
- Schepman K, Engelbert RH, Visser MM, et al. (2011). Kashin Beck disease: more than just osteoarthrosis: a cross-sectional study regarding the influence of body function-structures and activities on level of participation. Int Orthopaed 35:767–76
- Smeets RL, Veenbergen S, Arntz OJ, et al. (2006). A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor. Arthritis Rheum 54:1518–28
- Wang HY, Chen ZH. (2008). Matched pair study about the relationship between Kashin–Beck disease and the trace element selenium in hair. Chin J Ctrl Endem Dis 23:59–60
- Wang J, Li H, Li Y, et al. (2013). Speciation, distribution, and bioavailability of soil selenium in the Tibetan Plateau Kashin–Beck disease area – a case study in Songpan County, Sichuan Province, China. Biol Trace Element Res 156:367–75
- Wang S, Duan C, Zhang F, et al. (2013). Regulatory gene networks and signaling pathways from primary osteoarthritis and Kashin–Beck disease, an endemic osteoarthritis, identified by three analysis software. Gene 512:89–96
- Wang S, Guo X, Wang W, et al. (2012). Genome-wide study identifies the regulatory gene networks and signaling pathways from chondrocyte and peripheral blood monocyte of Kashin–Beck disease. Genes Cells 17:619–32
- Wang W, Guo X, Chen J, et al. (2008). Morphology and phenotype expression of types I, II, III, and X collagen and MMP-13 of chondrocytes cultured from articular cartilage of Kashin–Beck disease. J Rheumatol 35:696–702
- Xiong YM, Mo XY, Zou XZ, et al. (2010). Association study between polymorphisms in selenoprotein genes and susceptibility to Kashin–Beck disease. Osteoarthr Cartil 18:817–24
- Yang J, Wang T, Wu C, et al. (2010). Selenium level surveillance for the year 2007 of Keshan disease in endemic areas and analysis on surveillance results between 2003 and 2007. Biol Trace Element Res 138:53–9
- Yao Y, Pei F, Kang P. (2011). Selenium, iodine, and the relation with Kashin–Beck disease. Nutrition 27:1095–100
- Zhao ZJ, Li Q, Yang PZ, et al. (2013). Selenium: a protective factor for Kashin–Beck disease in Qing-Tibet Plateau. Biol Trace Element Res 153:1–4
- Zheng J, Wu C, Ma W, et al. (2013). Abnormal expression of chondroitin sulphate N-acetylgalactosaminyltransferase 1 and Hapln-1 in cartilage with Kashin–Beck disease and primary osteoarthritis. Int Orthopaed 37:2051–9